| |
| |
|
| Insider
Information: |
Derbyshire Adam C |
| Relationship: |
EVP Finance/CFO |
| City: |
Raleigh |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
218,463 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
218,463 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Salix Pharmaceuticals Ltd |
SLXP |
EVP Finance/CFO |
2014-08-22 |
218,463 |
2006-07-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2014-08-22 |
4 |
A |
$158.30 |
$3,286,783 |
D/D |
20,763 |
218,463 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2014-07-01 |
4 |
D |
$123.35 |
$303,194 |
D/D |
(2,458) |
197,700 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2014-04-17 |
4 |
A |
$100.66 |
$2,090,004 |
D/D |
20,763 |
200,158 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2014-01-09 |
4 |
AS |
$91.44 |
$2,744,515 |
D/D |
(30,001) |
179,395 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2014-01-09 |
4 |
OE |
$18.87 |
$566,218 |
D/D |
30,001 |
209,396 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2014-01-02 |
4 |
D |
$89.94 |
$821,602 |
D/D |
(9,135) |
179,395 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2013-07-01 |
4 |
D |
$66.15 |
$420,846 |
D/D |
(6,362) |
188,530 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2013-04-18 |
4 |
A |
$48.70 |
$1,189,303 |
D/D |
24,421 |
194,892 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2013-01-02 |
4 |
D |
$40.47 |
$248,081 |
D/D |
(6,130) |
170,471 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-12-26 |
4 |
AS |
$41.44 |
$2,486,382 |
D/D |
(60,000) |
176,601 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-12-26 |
4 |
OE |
$8.00 |
$720,000 |
D/D |
90,000 |
236,601 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-07-02 |
4 |
D |
$54.44 |
$340,141 |
D/D |
(6,248) |
146,601 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
21,711 |
152,849 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-02-28 |
4 |
AS |
$50.09 |
$631,134 |
D/D |
(12,600) |
131,138 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-02-28 |
4 |
OE |
$4.07 |
$51,239 |
D/D |
12,600 |
143,738 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-02-13 |
4 |
AS |
$50.00 |
$644,550 |
D/D |
(12,891) |
131,138 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-02-13 |
4 |
OE |
$4.07 |
$52,423 |
D/D |
12,891 |
144,029 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-01-18 |
4 |
AS |
$4.07 |
$1,525 |
D/D |
(375) |
131,138 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-01-18 |
4 |
OE |
$4.07 |
$1,525 |
D/D |
375 |
131,513 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-01-17 |
4 |
AS |
$50.06 |
$168,098 |
D/D |
(3,358) |
131,138 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-01-17 |
4 |
OE |
$4.07 |
$13,656 |
D/D |
3,358 |
134,496 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2012-01-03 |
4 |
D |
$47.85 |
$136,468 |
D/D |
(2,852) |
131,138 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2011-07-01 |
4 |
D |
$39.83 |
$447,769 |
D/D |
(11,242) |
133,990 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2011-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
25,955 |
145,232 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2010-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
19,520 |
119,277 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
